Emmett

Emmett Wilson, born in December 2016, followed what appeared to be a healthy developmental trajectory for the first four years of his life. As an educator with specialist qualifications in special education and autism, I monitored his milestones closely. While he had minor language delays and sensory-seeking behaviors—specifically a desire for deep pressure ("Mommy, tight me")—his pediatrician assured us he was meeting his marks. By his fourth birthday, through speech-language pathology, Emmett was caught up with his peers. He was a typical junior kindergartner: he told jokes, invented imaginary games, had safety skills, and was beginning to read and spell his name.

The shift was not a plateau, but a "cliff-edge" regression that began shortly after his fourth birthday in 2021. Our nanny first noticed his attention waning and his emerging literacy skills vanishing. Within weeks, the situation turned catastrophic.

Emmett went from being a verbal, happy child one night to waking up in the middle of the night suffering from what seemed like hallucinations or night terrors, screaming unintelligibly while slamming his head against walls and looking at his own hands as if they were foreign objects. This was not a slow drift into autism; this was an acute neurological collapse that lasted a week, and one from which Emmett has never recovered.

In our search for an etiology, Emmett has undergone a battery of tests that most adults will never face. Despite the initial online ADOS assessment labeling him with Level 2 autism two weeks prior to his severe regression event, Emmett continued to slowly lose more skills and ended up with a diagnosis of autism with Level 3 support needs. We couldn’t believe this was autism and feared a brain tumor or stroke. Our clinical journey included:

 * Neurological Imaging: Multiple MRIs (with and without contrast) and prolonged/overnight EEGs to monitor for subclinical seizures or structural anomalies.

 * Genetic Sequencing: Initial genetic panels were denied because of the "Autism" label; we had to fight for Whole Exome Sequencing (WES) and Genome Sequencing. He is currently enrolled in the Decoder research study for long-read genetic coding.

 * Metabolic & Immunology: Lumbar punctures and consultations with neuroinflammatory clinics (ruling out PANS/PANDAS).

 * Specialist Consultations: Neurology, Endocrinology, and Psychopharmacology.

Every standard test returned "normal," leaving us in a diagnostic vacuum where "autism" is used as a catch-all for a clear medical event. We have pursued every available therapy in Ontario, often paying out-of-pocket due to systemic delays:

 * Behavioral & Physical: Two years of full-time ABA and an additional half year of SBT mode; a year and a half in a specialized school for disabled children (until he was asked to leave due to the school being unable to support his needs); and physiotherapy, occupational therapy, rebound (trampoline) therapy, aquatic therapy, and music therapies.

 * Alternative Trials: Safe and Sound Protocol, Spiral Praxis, and equine therapy.

 * Pharmacology: A "slew" of medications; he is currently on Risperidone and Melatonin, as ADHD medications exacerbated his self-injury.

 * Deep Brain Stimulation (DBS): In November 2025, Emmett began a 15-month clinical trial for DBS, with electrodes implanted to manage severe self-injurious behaviors (SIB).

Emmett is now nine years old. He is an "unreliable speaker," using an AAC device with 108 icons to communicate basic needs, though his receptive language remains strong. His life is defined by high-risk behaviors—eloping, aggression, and self-injury.

We refuse to accept that a child can lose the ability to speak and function safely at age four and have it labeled "just autism." The current DSM/ICD classification subsumes these children into a broad spectrum, making them invisible to targeted research. We are desperate for the medical community to investigate late-age regression by reviving research (like that of Abha Gupta at Yale) into the unique pathophysiology of Childhood Disintegrative Disorder (CDD) phenotypes.

Emmett is still "in there," and his story deserves to be more than a footnote in a broad spectrum. He deserves a medical community that views his loss of skills as an urgent mystery to be solved, not a diagnosis to be accepted.